Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Apr;3(2):165-71.
doi: 10.1007/s11906-001-0032-8.

Regulation of sodium/potassium ATPase activity: impact on salt balance and vascular contractility

Affiliations
Review

Regulation of sodium/potassium ATPase activity: impact on salt balance and vascular contractility

A Aperia. Curr Hypertens Rep. 2001 Apr.

Abstract

Na+,K+-ATPase distributes ions between the intracellular and extracellular space and is responsible for total-body sodium homeostasis. The activity of this ion pump is regulated by catecholamines and peptide hormones; by the ligand of Na+,K+-ATPase, ouabain; and by direct interaction with cytoskeleton proteins. This review summarizes recent advances in the field of short-term regulation of Na+,K+-ATPase and the implications of these advances for the regulation of blood pressure. Renal Na+,K+-ATPase activity is bidirectionally regulated by natriuretic and antinatriuretic hormones, and a shift in the balance between these forces may lead to salt retention and hypertension. Dopamine plays a key role in this interactive regulation. By inhibiting vascular Na+,K+-ATPase activity, an excess of circulating ouabain may increase calcium concentration in vascular cells and lead to increased vascular contractility. Finally, mutations in cytoskeleton proteins may stimulate renal Na+,K+-ATPase activity by way of protein/protein interaction and lead to salt retention and hypertension. Abnormalities in the systems regulating Na+,K+-ATPase should be explored further in the search for the multiple causes of essential hypertension.

PubMed Disclaimer

References

    1. Exp Clin Endocrinol Diabetes. 2000;108(7):449-54 - PubMed
    1. Acta Physiol Scand Suppl. 1998 Aug;643:69-77 - PubMed
    1. Hypertension. 1997 Jan;29(1 Pt 2):228-34 - PubMed
    1. Proc Natl Acad Sci U S A. 1989 Oct;86(20):8068-72 - PubMed
    1. J Biol Chem. 1998 Jul 24;273(30):18681-4 - PubMed

MeSH terms

Substances

LinkOut - more resources